Viewing StudyNCT00105235



Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00105235
Status: COMPLETED
Last Update Posted: 2012-12-27
First Post: 2005-03-10

Brief Title: Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
Liver Transplantation
Liver Disease
Keywords:
Name View
transplantation View
liver transplant View
rejection View
tolerance View
antibody induction View